V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250006990 | 250009643 | 1.63 | 62.6 | Palliative (P) | 2016-10-03 | 2016-10-03 | ANAGRELIDE | N | N | 250030861 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 250006991 | 250004927 | 0 | 47.3 | Disease modification (D) | 2014-11-05 | 2014-11-05 | CYCLOPHOSPHAMIDE + FLUDARABINE | N | N | 250030862 | AZACITIDINE |
| 250006992 | 250004928 | null | 81.95 | Neo-adjuvant (N) | 2016-10-06 | 2016-10-13 | RUXOLITINIB | N | N | 250030863 | IMATINIB |
| 250006993 | 250004929 | 0 | 52.5 | Palliative (P) | 2014-02-16 | 2014-02-16 | ANAGRELIDE | N | N | 250030864 | RUXOLITINIB |
| 250006994 | 250004930 | 1.7 | 61 | Disease modification (D) | 2016-03-05 | 2016-03-05 | Imatinib 400mg | 02 | N | 250030868 | INTERFERON |
| 250006995 | 250004931 | null | null | Disease modification (D) | 2013-06-16 | 2013-06-16 | Trial Unspecified | 01 | null | 250030872 | TRIAL |
| 250006996 | 250009644 | 1.77 | null | Not known (9) | 2013-08-28 | 2013-08-28 | CHOP R - 21 days | 02 | N | 250030873 | BUSULPHAN |
| 250006997 | 250004932 | null | 70.9 | null | 2013-10-22 | 2013-10-28 | DA 3 + 10 | N | N | 250030881 | CVP R |
| 250006998 | 250004932 | null | 69 | Palliative (P) | 2016-03-31 | 2016-04-06 | RUXOLITINIB | 02 | N | 250030881 | BUSULPHAN |
| 250007001 | 250004933 | 0 | 10.5 | Curative (C) | 2015-07-01 | 2015-07-29 | BENDAMUSTINE + RITUXIMAB | 02 | N | 250030890 | RUXOLITINIB |
| 250007002 | 250004934 | 1.77 | 91.6 | Palliative (P) | 2018-04-04 | 2018-04-10 | BUSULFAN | 01 | N | 250030897 | PEG INTERFERON |
| 250007003 | 250009646 | 1.65 | 0 | Palliative (P) | 2015-08-31 | 2015-09-19 | PEG INTERFERON | N | N | 250030898 | RUXOLITINIB |
| 250007004 | 250011583 | null | 82.4 | null | 2014-08-27 | 2014-08-27 | RUXOLITINIB | 02 | N | 250030899 | RUXOLITINIB |
| 250007005 | 250011583 | null | 67 | Palliative (P) | null | 2017-05-15 | RUXOLITINIB | null | N | 250030899 | PEG INTERFERON |
| 250007006 | 250011583 | 1.5 | 63.8 | null | 2013-10-14 | 2013-10-14 | RUXOLITINIB | N | null | 250030899 | RUXOLITINIB |
| 250007007 | 250004935 | 1.84 | 0 | Disease modification (D) | 2013-03-23 | 2013-04-02 | ANAGRELIDE | 2 | N | 250030913 | RITUXIMAB |
| 250007008 | 250004936 | 1.8 | 58.7 | Palliative (P) | 2015-11-19 | 2015-11-22 | IMATINIB | 02 | N | 250030914 | BUSULPHAN |
| 250007009 | 250004937 | null | 50.1 | null | 2016-02-10 | 2016-02-10 | RUXOLITINIB | Y | N | 250030916 | ABVD |
| 250007010 | 250004938 | 1.68 | null | Palliative (P) | 2014-06-30 | 2014-06-30 | PEG INTERFERON | N | N | 250030917 | RITUXIMAB |
| 250007011 | 250004939 | 0 | null | Curative (C) | 2014-03-29 | 2014-04-23 | DA | 02 | N | 250030918 | RUXOLITINIB |
| 250007012 | 250004939 | 1.66 | 83.8 | Palliative (P) | 2013-07-31 | 2013-08-29 | RUXOLITINIB | N | N | 250030918 | RUXOLITINIB |
| 250007013 | 250004940 | 1.81 | 73.8 | Not known (9) | 2017-05-27 | 2017-07-14 | CHOP R - 21 days | N | N | 250030922 | IMATINIB |
| 250007014 | 250004941 | null | 88.7 | Neo-adjuvant (N) | 2015-09-08 | 2015-09-08 | RUXOLITINIB | 02 | null | 250030923 | RUXOLITINIB |
| 250007015 | 250004941 | 1.67 | 78 | Palliative (P) | 2013-08-08 | 2013-08-21 | RUXOLITINIB | null | N | 250030923 | BUSULPHAN |
| 250007016 | 250004942 | null | 63.4 | Palliative (P) | 2017-04-12 | 2017-04-12 | CHOP R - 21 days | 1 | N | 250030925 | TRASTUZUMAB |
| 250007017 | 250004943 | 1.61 | 64 | Palliative (P) | 2014-04-10 | 2014-04-11 | RUXOLITINIB | 02 | N | 250030933 | RUXOLITINIB |
| 250007018 | 250004944 | 1.7 | 70.7 | Curative (C) | 2013-10-20 | 2013-11-03 | Rituximab | N | N | 250030934 | TRIAL |
| 250007019 | 250004945 | 1.79 | 0 | Disease modification (D) | 2014-10-13 | 2014-10-13 | Azacitidine | N | N | 250030938 | TRIAL |
| 250007021 | 250004947 | 1.55 | 96.5 | Adjuvant (A) | 2017-03-09 | 2017-03-15 | RUXOLITINIB | 1 | null | 250030951 | CHOP R |
| 250007022 | 250004948 | 0 | 116 | Palliative (P) | 2017-10-05 | 2017-10-10 | Chlorambucil | N | N | 250030952 | TRIAL |
| 250007023 | 250004949 | 1.52 | null | Not known (9) | 2016-10-02 | 2016-10-22 | PEG INTERFERON | N | N | 250030955 | RUXOLITINIB |
| 250007024 | 250004949 | 0 | 62.2 | Curative (C) | 2014-11-09 | 2014-11-09 | RAVVA TRIAL | 02 | N | 250030955 | CVP R |
| 250007025 | 250011584 | null | 81.8 | null | 2013-08-26 | 2013-09-04 | Busulfan Oral | null | N | 250030967 | ENZALUTAMIDE |
| 250007026 | 250011584 | null | null | null | 2013-10-15 | 2013-10-15 | RUXOLITINIB | N | N | 250030967 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 250007027 | 250004950 | 1.66 | 87.6 | Disease modification (D) | 2017-04-08 | 2017-05-03 | Rituximab | N | N | 250030969 | ATG + BUSULFAN + FLUDARABINE |
| 250007028 | 250004951 | 1.8 | 77.9 | Curative (C) | 2015-06-14 | 2015-06-18 | Rituximab | 02 | N | 250030970 | RUXOLITINIB |
| 250007029 | 250004952 | 1.65 | 76.3 | Curative (C) | 2015-10-23 | 2015-10-23 | RUXOLITINIB | N | N | 250030976 | CVD |
| 250007030 | 250004953 | 1.63 | 67.7 | Palliative (P) | 2016-04-27 | 2016-04-27 | FCR IV - Cycle 1 | 2 | N | 250030977 | RUXOLITINIB |
| 250007031 | 250009650 | 1.68 | 75 | Palliative (P) | 2016-08-18 | 2016-08-18 | Trial Unspecified | N | null | 250030979 | TRIAL |
| 250007032 | 250004954 | null | null | null | 2016-07-27 | 2016-07-27 | RUXOLITINIB | 01 | N | 250030982 | BUSULPHAN |
| 250007033 | 250004955 | 1.77 | 76.3 | Palliative (P) | 2013-12-11 | 2013-12-11 | FLUDARABINE + MELPHALAN | N | N | 250030984 | IMATINIB |
| 250007034 | 250004956 | 1.77 | 52.6 | Disease modification (D) | 2017-02-14 | 2017-02-14 | BENDAMUSTINE + RITUXIMAB | 02 | N | 250030988 | LENALIDOMIDE |
| 250007035 | 250004956 | null | 102 | Curative (C) | 2014-08-09 | 2014-09-24 | RUXOLITINIB | N | N | 250030988 | RUXOLITINIB |
| 250007036 | 250004957 | null | null | Curative (C) | 2013-03-19 | 2013-03-19 | Busulfan Oral | null | N | 250030992 | PEG INTERFERON |
| 250007037 | 250004958 | 1.81 | 48 | null | 2015-03-24 | 2015-03-25 | CHLORAMBUCIL + OBINUTUZUMAB | N | N | 250030994 | RUXOLITINIB |
| 250007038 | 250004958 | null | 92.8 | Neo-adjuvant (N) | 2015-11-19 | 2015-11-19 | RUXOLITINIB | 2 | N | 250030994 | BENDAMUSTINE + RITUXIMAB |
| 250007039 | 250004959 | 1.55 | null | Disease modification (D) | 2016-11-28 | 2016-12-09 | CHOP R - 21 days | 2 | N | 250030997 | BUSULPHAN |
| 250007040 | 250004960 | 0 | 0 | Palliative (P) | 2016-09-06 | 2016-09-06 | CHOP R - 21 days | N | N | 250030998 | RUXOLITINIB |
| 250007041 | 250004961 | 1.6 | null | Adjuvant (A) | 2018-01-19 | 2018-02-24 | RUXOLITINIB | N | N | 250031007 | RUXOLITINIB |
| 250007042 | 250004962 | null | 74 | Disease modification (D) | 2017-10-31 | 2017-11-09 | RUXOLITINIB | null | null | 250031012 | PEG INTERFERON |